Diabetic eye screening with variable screening intervals based on individual risk factors is safe and effective in ophthalmic practice.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationEstil S, Steinarsson AÞ, Einarsson S, Aspelund T, Stefánsson E. Diabetic eye screening with variable screening intervals based on individual risk factors is safe and effective in ophthalmic practice [published online ahead of print, 2020 Mar 25]. Acta Ophthalmol. 2020;10.1111/aos.14425. doi:10.1111/aos.14425
AbstractPurpose: To test in a 'real world' diabetic eye-screening programme, a computer-based personal risk evaluation for progression to sight-threatening diabetic retinopathy. Screening intervals were individualized, and clinical outcomes, safety and cost-effectiveness documented. Methods: The RETINARISK algorithm was used in an ophthalmology clinic in Norway. The diabetes cohort was divided on voluntary basis into two groups: one with variable screening intervals based on their personal risk profile and the other group with conventional fixed interval diabetic eye screening. Compliance, clinical outcomes, safety and health economics were evaluated. A total of 843 diabetic patients participated in the program 2014-2019. A total of 63 had type 1 and 780 type 2 diabetes. A total of 671 patients had no diabetic retinopathy at baseline and 171 had retinopathy. Results: A total of 444 (53%) diabetic patients were included in the personal risk profile program and 399 in the fixed interval group. The RETINARISK algorithm calculated 563 screening intervals for the variable interval group, which was 23 ± 16 months (mean ± SD), compared to 14 ± 5 months for the group with fixed screening intervals. Due to selection bias, the two groups could not be directly compared. We did not experience any delay in detecting diabetic retinal changes when using the personal risk profile program. Conclusion: The RETINARISK algorithm was safe and effective in a diabetic screening program in an ophthalmology clinic over 5 years. The use of the program reduces the mean frequency of screening visits and liberates valuable time in ophthalmic practice to be used on high-risk diabetic patients or other patient groups.
Rights© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
- Patients' Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use.
- Authors: Keenum Z, McGwin G Jr, Witherspoon CD, Haller JA, Clark ME, Owsley C
- Issue date: 2016 Nov 1
- Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy.
- Authors: Aspelund T, Thornórisdóttir O, Olafsdottir E, Gudmundsdottir A, Einarsdóttir AB, Mehlsen J, Einarsson S, Pálsson O, Einarsson G, Bek T, Stefánsson E
- Issue date: 2011 Oct
- Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
- Authors: Kristinsson JK
- Issue date: 1997
- Evaluation of Automated Teleretinal Screening Program for Diabetic Retinopathy.
- Authors: Walton OB 4th, Garoon RB, Weng CY, Gross J, Young AK, Camero KA, Jin H, Carvounis PE, Coffee RE, Chu YI
- Issue date: 2016 Feb
- Incidence of sight-threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review.
- Authors: Groeneveld Y, Tavenier D, Blom JW, Polak BCP
- Issue date: 2019 Oct